Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.
Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.
What is your view on the bill in Congress to reduce healthcare costs and how it approaches surprise medical billing?
So, the debate in Washington is whether or not we’re going to have a Medicare-plus rate to reimburse on surprise bills, or are we going to go into arbitration. And, I think what arbitration does is really codify the practice of surprise billing, which is a way around provider agreements. Instead of patients being able to really see relief, while the bill may relieve the patients upfront, they’re going to get the [charges] in added premiums, increased deductibles, increased co-pays; so, ultimately, a patient is going to pay for a surprise bill.
We would rather see Congress act on policies that allow for a long-term, stable arrangement between providers and insurance companies, rather than have a system where an arbitrator picks one price versus the other.
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More